Reversal of EGFR inhibitors' resistance by co-delivering EGFR and integrin αvß3 inhibitors with nanoparticles in non-small cell lung cancer.
Biosci Rep
; 39(8)2019 08 30.
Article
in En
| MEDLINE
| ID: mdl-31316001
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Integrin alphaVbeta3
/
Nanoparticles
/
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Biosci Rep
Year:
2019
Document type:
Article
Affiliation country:
China
Country of publication:
Reino Unido